Insulin Degludec (U-100) Prefilled Pens and Sodium phenylbutyrate
Determining the interaction of Insulin Degludec (U-100) Prefilled Pens and Sodium phenylbutyrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Prefilled Pens-Sodium Phenylbutyrate Powder
- Insulin Degludec (U-100) Prefilled Pens-Sodium Phenylbutyrate Tablets
- Insulin Degludec (U-100) Prefilled Pens-Sodium phosphate dibasic and sodium phosphate monobasic
- Insulin Degludec (U-100) Prefilled Pens-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Insulin Degludec (U-100) Prefilled Pens-Sodium phosphate p 32 Intravenous
- Insulin Degludec (U-100) Prefilled Pens-Sodium Phosphates
- Sodium phenylbutyrate-Insulin Degludec (U-100) Vials
- Sodium phenylbutyrate-Insulin Degludec (U-200) Prefilled Pens
- Sodium phenylbutyrate-Insulin degludec and liraglutide
- Sodium phenylbutyrate-Insulin degludec and liraglutide Subcutaneous
- Sodium phenylbutyrate-Insulin degludec Subcutaneous
- Sodium phenylbutyrate-Insulin detemir